Equity Overview
Price & Market Data
Price: $0.35
Daily Change: $0.00 / 0.00%
Daily Range: $0.34 - $0.381
Market Cap: $1,153,122
Daily Volume: 6,078
Performance Metrics
1 Week: 112.9%
1 Month: 94.44%
3 Months: -53.33%
6 Months: -55.52%
1 Year: 39.89%
YTD: -53.33%
Company Details
Employees: 1
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; and intravenous tramadol for the treatment of post-operative acute pain. It also develops BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is headquartered in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.